Research progress on dose-effect-toxicity relationship of EGFR- and ALK-tyrosine kinase inhibitors in the treatment of non-small cell lung cancer
Pei Yihan, Li Yue, Bi Yunyan, Guo Nan, Zhang Wen
Adverse Drug Reactions Journal . 2024, (3): 178 -183 .  DOI: 10.3760/cma.j.cn114015-20231129-00845